Dealing Together: Fighting Heart Disease and Obesity Simultaneously

Published Date: 14 Mar 2023

"You can't treat one of these conditions and ignore the others," says the author of the new review, explaining how obesity can affect the diagnosis and treatment of these heart conditions.

Read Full News

Latest News

TADV Saves Limbs in No-Option CLTI Patients

More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure while enjoying improved wound healing and reduced pain.

Underground Hospitals: Is Combat Medicine Entering a New Era?

Ukrainian clinicians increasingly rely on protected underground facilities as drone threats complicate evacuation and strain traditional battlefield treatment models.

France Focuses on Drugs That Raise Fall Risk in Older Adults

Long-term benzodiazepines and anticholinergics drive falls in seniors; prioritize nonpharmacologic care and deprescribing to cut injuries and hospitalizations.

Uraemic Marker Predicts Mortality After Kidney Transplant

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

GLP-1 Drugs Tied to Cardiovascular Benefits in T1D

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Transient Neurologic Symptoms: What Clinicians Miss

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Latest News

More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure while enjoying improved wound healing and reduced pain.

Ukrainian clinicians increasingly rely on protected underground facilities as drone threats complicate evacuation and strain traditional battlefield treatment models.

Long-term benzodiazepines and anticholinergics drive falls in seniors; prioritize nonpharmacologic care and deprescribing to cut injuries and hospitalizations.

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

News All Time

Preventive Care With the Most Bang for Your Buck

An analysis of USPSTF and ACIP recommendations shows wide variation in impact, helping clinicians prioritize care during time-constrained visits.

Long Delays in Cardiac Amyloidosis Diagnosis Persist

Most older adults with transthyretin cardiac amyloidosis face a several-month delay in diagnosis after a heart failure diagnosis, despite overall increased diagnostic frequency of amyloidosis.

Early Physical Activity Safe After MI

Patients who started physical activity within a week of discharge for a heart attack have no greater cardiovascular risk than less active patients in a recent study.

Clopidogrel Beats Aspirin Long-Term After PCI

When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding events relative to aspirin.

Jehovah’s Witnesses Allow Autologous Blood in Brazil

Jehovah’s Witnesses now allow members to choose to use their own blood in some procedures, reigniting debate over bloodless surgery, patient autonomy, and broader blood-conservation care.

BP After Stroke Thrombectomy: Individualization Needed?

Results of a new trial suggest that BP targets after thrombectomy in patients with acute ischemic stroke may need to be individualized depending on several different patient characteristics.

New STEMI Score Predicts Mortality After Angioplasty

A new seven factor score predicts long term mortality after ST-elevation myocardial infarction in patients who undergo angioplasty, and it performs similarly to or better than existing models.

Too Few Children With Overweight/Obesity Assessed for OSA

Children were more likely to undergo an evaluation if they had public insurance, had a higher BMI, had English as a primary language, or were a toddler or preschool aged.

Syncing Sleep, Fasting Improves Blood Sugar Markers

Patients interested in time-restricted eating should make sense it works their own sleep cycle.

Lipoprotein(a) Levels Matter Even in Primary Prevention

Elevated lipoprotein(a) levels are associated with increased non-calcified plaque volume and higher odds of high-risk features at the plaque level in adults without prior coronary artery disease.

Severe Chest Pain in Newly Diagnosed Colorectal Cancer

Case study illustrates iatrogenic risks not to be underestimated

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Recommended News For You

Belzutifan Combo Could be Second-Line Option in Advanced RCC

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

Leukemia cells evade treatment by reshaping their mitochondria, researchers discover

Dense breasts: What it means and what women can do about screening

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Recommended Articles For You

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs 

Understanding the HAS-BLED Score: What It Is and Why It Matters  

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers 

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

2.

Lymph node transfer reduces arm swelling after breast cancer surgery, study shows

3.

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

4.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

5.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

1.

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer

2.

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies

3.

Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment

4.

Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression

5.

Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV

3.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

5.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot